Literature DB >> 6357642

The Eck fistula in animals and humans.

T E Starzl, K A Porter, A Francavilla.   

Abstract

In all species so far studied, including man, portacaval shunt causes the same changes in liver morphology, including hepatocyte atrophy, fatty infiltration, deglycogenation, depletion and disorganization of the rough endoplasmic reticulum (RER) and its lining polyribosomes, and variable but less specific damage to other organelles. Many, perhaps all, biosynthetic processes are quickly depressed, largely secondary to the selective damage to the RER, which is the "factory" of the cell. These structural and metabolic changes in the liver after portal diversion are caused by the diversion around the liver of the hepatotrophic substances in portal venous blood, of which endogenous insulin is the most important. In experimental animals, the injury of Eck's fistula can be prevented by infusing insulin into the tied-off hilar portal vein. The subtle but far-reaching changes in hepatic function after portal diversion have made it possible to use this procedure in palliating three inborn errors of metabolism: glycogen storage disease, familial hypercholesterolemia, and alpha 1-antitrypsin deficiency. In these three diseases, the abnormalities caused by portal diversion have counteracted abnormalities in the patients that were caused by the inborn errors. In these diseases, amelioration of the inborn errors depends on the completeness of the portal diversion. In contrast, total portal diversion to treat complications of portal hypertension is undesirable and always will degrade hepatic function if a significant amount of hepatopetal portal venous blood is taken from the liver. When total portal diversion is achieved (and this is to be expected after all conventional shunts), the incidence of hepatic failure and hepatic encephalopathy is increased. If portal diversion must be done for the control of variceal hemorrhage, a selective procedure such as the Warren procedure is theoretically superior to the completely diverting shunt. In practice, better patient survival has not been achieved after selective shunts than after conventional shunts, but the incidence of hepatic encephalopathy has been less.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6357642      PMCID: PMC3154772          DOI: 10.1016/s0011-3840(83)80010-0

Source DB:  PubMed          Journal:  Curr Probl Surg        ISSN: 0011-3840            Impact factor:   1.909


  206 in total

1.  LIVER DEGLYCOGENATION AFTER PORTACAVAL TRANSPOSITION.

Authors:  A W SEXTON; T L MARCHIORO; W R WADDELL; T E STARZL
Journal:  Surg Forum       Date:  1964

2.  A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices.

Authors:  G W Johnston; H W Rodgers
Journal:  Br J Surg       Date:  1973-10       Impact factor: 6.939

3.  Fine structural and growth characteristics of cultured rat liver cells. Insulin effects.

Authors:  L E Gerschenson; T Okigaki; M Andersson; J Molson; M B Davidson
Journal:  Exp Cell Res       Date:  1972-03       Impact factor: 3.905

4.  The metabolic basis of portasystemic encephalopathy and the effect of selective vs nonselective shunts.

Authors:  W D Warren; D Rudman; W Millikan; J T Galambos; A A Salam; R B Smith
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969

5.  A clinical investigation of the portacaval shunt. V. Survival analysis of the therapeutic operation.

Authors:  F C Jackson; E B Perrin; W R Felix; A G Smith
Journal:  Ann Surg       Date:  1971-10       Impact factor: 12.969

6.  Sex-dependent differences in the effects of portacaval anastomosis on hepatic monooxygenases in rats.

Authors:  Y Hirokata; S Tong; Z H Siddik; M A Trush; E G Mimnaugh; T E Gram
Journal:  Biochem Pharmacol       Date:  1982-02-15       Impact factor: 5.858

7.  Effect of portasystemic shunt operations on hepatic portal perfusion.

Authors:  L F Rikkers; F J Miller; P Christian
Journal:  Am J Surg       Date:  1981-01       Impact factor: 2.565

8.  Portacaval shunt with arterialization of the portal vein by means of a low flow arteriovenous fistula.

Authors:  R J Adamons; K Butt; S Iyer; J DeRose; C R Dennis; M Kinkhabwala; D Gordon; E Martin
Journal:  Surg Gynecol Obstet       Date:  1978-06

9.  Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

Authors:  T E Starzl; K Watanabe; K A Porter; C W Putnam
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

10.  Portal hemodynamics, intestinal absorption, and postshunt encephalopathy.

Authors:  L F Rikkers
Journal:  Surgery       Date:  1983-08       Impact factor: 3.982

View more
  31 in total

1.  The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967).

Authors:  Thomas E Starzl
Journal:  J Am Coll Surg       Date:  2002-11       Impact factor: 6.113

2.  Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors.

Authors:  A Francavilla; A Azzarone; G Carrieri; C Scotti-Foglieni; Q H Zeng; U Cillo; K Porter; T E Starzl
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

3.  [Liver transplantation in low portal vein flow: separation of portal vein areas with divided portal-venous and arterialized caval-venous liver perfusion. 1. Clinical case report].

Authors:  R Pichlmayr; G Gubernatis; H Grosse; W Seitz; S Mauz; I Ennker; M Mei; J Klempnauer; J Hauss; E R Kuse
Journal:  Langenbecks Arch Chir       Date:  1989

4.  Survival of human hepatocellular aggregates in athymic mice.

Authors:  C Ricordi; Y Zeng; B Carr; P Carroll; H L Rilo; A J Demetris; R Alejandro; D R Bereiter; J J Fung; A Tzakis
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

5.  Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage.

Authors:  N Murase; A J Demetris; T Furuya; S Todo; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1992-06       Impact factor: 1.066

6.  Studies of the hepatotrophic qualities of FK 506 and CyA.

Authors:  V Mazzaferro; C L Scotti-Foglieni; K A Porter; J Trejo Bellido; G Carrieri; S Todo; J J Fung; A Francavilla; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

7.  Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506.

Authors:  N Murase; A J Demetris; T Matsuzaki; A Yagihashi; S Todo; J Fung; T E Starzl
Journal:  Surgery       Date:  1991-07       Impact factor: 3.982

8.  Evidence that canine pancreatic islets promote the survival of human hepatocytes in nude mice.

Authors:  C Ricordi; Y Zeng; A Tzakis; R Alejandro; A J Demetris; J Fung; D R Bereiter; D H Mintz; T E Starzl
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

Review 9.  Intestinal transplantation.

Authors:  A G Tzakis; S Todo; T E Starzl
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

10.  Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Vladimir M Subbotin; Tadahiro Uemura; Michael Nalesnik; Anthony J Demetris; John J Fung; Thomas E Starzl
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.